SCHEMBL8894048

SCHEMBL8894048

COc1cccc2c1C1(C=CC2=O)OCCO1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TXNRD1 Q16881 2/20 0.58
TXNRD3 Q86VQ6 2/20 0.58
TXNRD2 Q9NNW7 2/20 0.58
TOP1 P11387 1/20 0.47
IDO1 P14902 2/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
ACHE P22303 1/20 0.38
ALDH1A1 P00352 3/20 0.37
LMNA P02545 3/20 0.37
MAPT P10636 3/20 0.37
APAF1 O14727 1/20 0.37
MITF O75030 1/20 0.37
HTT P42858 1/20 0.37
NQO1 P15559 1/20 0.36
POR P16435 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8893539 0.75 TOP1 (0.53) TXNRD1TXNRD3TXNRD2TOP1IDO1
SCHEMBL30003440 0.65 TOP1 (1.00) TXNRD1TXNRD3TXNRD2TOP1IDO1
SCHEMBL29018326 0.65 TOP1 (0.67) TOP1IDO1CA1CA2CA7
SCHEMBL3414850 0.65 TOP1 (1.00) TXNRD1TXNRD3TXNRD2TOP1IDO1
SCHEMBL30882513 0.65 CA1 (0.44) TOP1IDO1CA1CA2CA7
SCHEMBL12896658 0.62 RET (0.54) TOP1CA1CA2CA7CA9
SCHEMBL384815 0.60 TOP1 (0.55) TOP1CA1CA2CA7CA9
SCHEMBL29378366 0.60 TOP1 (0.55) TOP1CA1CA2CA7CA9
SCHEMBL15613862 0.59 TXNRD1 (0.44) TXNRD1TXNRD3TXNRD2MAPTHPGD
SCHEMBL768807 0.59 MAPT (0.55) TOP1ACHEALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5594158-A Processes for producing doxorubicin, daunomycinone, and derivatives of doxorubicin THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 1997-01-14 US disclosed
US-5200513-A Processes for producing doxorubicin, daunomycinone, and derivatives of doxorubicin BOARD OF REGENTS, UNIVERSITY OF NEBRASKA-LINCOLN (US) 1993-04-06 US disclosed
EP-0523289-A1 Processes for producing doxorubicin, daunomycinone, and derivatives of doxorubicin Board of Regents of the University of Nebraska (US) 1993-01-20 EP disclosed